C-Path
ActiveSummary
The computed 12-month bankruptcy probability of C-Path is 1.7% (moderate). The 2025 annual accounts show negative equity (-€287,620) and a net result of -€537,258. Equity is shrinking by about 40% per year across the filed financial years. Its solvency ranks better than 9% of 3,343 sector peers (NACE 62, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
1 director, last change in 2025
Board 1
DE SASMEESTER
CurrentDirector · since 29-08-2025 · Limited partnership · permanent representative: Joris Pieter De Gussem
Permanent representatives 1
Joris Pieter De Gussem
CurrentPermanent representative · since 29-08-2025 · for DE SASMEESTER
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 5 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
2 people since 2025, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| DE SASMEESTER |
|
| Life Sciences Consulting bv |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.